Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Hp7 6 X Drops is a Health Canada–registered human drug (DIN 01976109) held by Metagenics, Inc., containing Sabadilla. Health Canada lists its status as Cancelled Post Market (status date 29 Aug 2006). Nexara Health has matched 16 registrations of Sabadilla across 2 other regulated markets, 2 of them in the same strength and dosage form.

Health Canada registration

DIN01976109
Brand nameHp7
Active ingredientSabadilla
Strength6 X
Dosage formDrops
RouteOral
CompanyMetagenics, Inc.
StatusCancelled Post Market — 29 Aug 2006
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Sabadilla registered in other markets

16 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesLice Ladies Defend ConditionerLice Ladies Atlanta, LLCLiquidlistedFDA NDC
United StatesSabadillaHerbamed AGLiquidFDA NDC
NetherlandsSabadillaBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMUitsluitend apotheek of drogistEU national register
NetherlandsSabadillaBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMGlobuliUitsluitend apotheek of drogistEU national register
United StatesBestmade Natural Products SabadillaBestmade Natural ProductsTablet, SolublelistedFDA NDC
United StatesEvictLice Ladies Atlanta, LLCSolutionlistedFDA NDC
United StatesLice Ladies DefendLice Ladies Atlanta, LLCShampoolistedFDA NDC
United StatesLice Ladies PreventLice Ladies Atlanta, LLCSpraylistedFDA NDC
United StatesSabadillaHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesSabadillaHahnemann Laboratories, INC.PelletlistedFDA NDC

See every manufacturer of Sabadilla worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Hp7 (DIN 01976109) marketed in Canada?

No. Health Canada lists DIN 01976109 as Cancelled Post Market as of 29 Aug 2006.

Who holds the Canadian licence for this product?

Metagenics, Inc. is the company of record in the Health Canada Drug Product Database.

Is Sabadilla registered outside Canada?

Yes — Nexara Health has matched 16 registrations in 2 other markets, including 2 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 01976109, status date 2006-08-29; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 01976109, status date 2006-08-29; national medicine registries: EU national register, FDA NDC.

Health Canada Drug Product Database (DPD), DIN 01976109, status date 2006-08-29; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.